< Back to search
Filter
1

Hyperbaric Oxygen Therapy and Allogeneic Peripheral Blood Stem Cell (PBSC) Transplant

for
Acute Myeloid Leukemia, Myelodysplastic Syndromes,
Location: Rochester NY
Sponsor: Omar Aljitawi

Sex: All

Age: 18 - 70+

Code: NCT03964506

Early_phase1, Recruiting

CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML

for
Acute Myeloid Leukemia
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18 - 70

Code: NCT05558124

Phase1, Recruiting

Massage Impact on Sleep in Pediatric Oncology

for
Cancer, Pediatric Cancer, Chemotherapy Effect,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 12 - 21

Code: NCT06892158

Recruiting

Ziftomenib Maintenance Post Allo-HCT

for
Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission,
Location: Boston MA, Columbus OH
Sponsor: Massachusetts General Hospital

Sex: All

Age: 18+

Code: NCT06440135

Phase1, Recruiting

A Phase I Study Investigating the Combination of the Menin Inhibitor Ziftomenib With Venetoclax and Gemtuzumab in Pediatric Patients With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 3 - 21

Code: NCT06448013

Phase1, Recruiting

Interested in new acute myeloid leukemia trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

for
Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT04047641

Phase1, Phase2, Recruiting

Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

for
Acute Myeloid Leukemia, Myelodysplastic Syndrome
Location: Boston MA, New Haven CT, Hackensack NJ, Montreal,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06419634

Phase1, Recruiting

211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia

for
Acute Lymphoblastic Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT03128034

Phase1, Phase2, Recruiting

A PALG Prospective Multicenter Clinical Trial to Compare the Efficacy of Two Standard Induction Therapies (DA-90 vs DAC) and Two Standard Salvage Regimens (FLAG-IDA vs CLAG-M) in AML Patients ≤ 60 Years Old

for
Acute Myeloid Leukemia
Location: New York NY
Sponsor: Polish Adult Leukemia Group

Sex: All

Age: 18 - 60

Code: NCT03257241

Phase3, Recruiting

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

for
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Location: Clovis CA, Sacramento CA
Sponsor: Brian Jonas

Sex: All

Age: 18+

Code: NCT04905810

Phase2, Recruiting

Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

for
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18 - 65

Code: NCT02115295

Phase2, Recruiting

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT03737955

Phase2, Recruiting

Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases

for
Acute Leukemia of Ambiguous Lineage,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 0 - 65

Code: NCT06013423

Phase2, Recruiting

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

for
Acute Myeloid Leukemia (AML)
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06773208

Phase2, Recruiting

Pilot Imaging Study of Leukemia

for
Acute Lymphocytic Leukemia, Acute Myeloid Leukemia,
Location: Oklahoma City OK
Sponsor: University of Oklahoma

Sex: All

Age: 4 - 70+

Code: NCT03633955

Phase1, Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: St. John's, Boston MA, New Haven CT, Mineola NY,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase2, Phase3, Recruiting

Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AML

for
Acute Myeloid Leukemia
Location: Columbus OH
Sponsor: Nationwide Children's Hospital

Sex: All

Age: 1 - 24

Code: NCT05503134

Phase1, Phase2, Recruiting

Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid Leukemia

for
Acute Myeloid Leukemia
Location: Dallas TX, Portland OR
Sponsor: OHSU Knight Cancer Institute

Sex: All

Age: 18+

Code: NCT04659616

Phase1, Recruiting

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

for
Acute Leukemia, Acute Leukemia of Ambiguous Lineage,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 2+

Code: NCT06575296

Phase1, Recruiting

Vyxeos for Re-induction Treatment of Acute Myeloid Leukemia Patients With Persistent Disease After Induction

for
Blasts More Than 5 Percent of Bone Marrow Nucleated Cells,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18 - 70+

Code: NCT04049539

Phase1, Phase2, Recruiting